Biotech News

Legend Biotech Reports Third Quarter 2026 Results and Recent Highlights

Legend Biotech Corporation (LEGN)Legend Biotech CorporationEarnings

Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today reported its third quarter 2026 unaudited financial results and recent highlights.

Related news

Legend Biotech Corporation

Global Cell Therapy Company Legend Biotech develops and commercializes cell therapies for cancer and other serious diseases. CARVYKTI CARVYKTI, or ciltacabtagene autoleucel, is a one-time BCMA-directed CAR T-cell therapy for multiple myeloma developed and commercialized with Johnson & Johnson. Global Manufacturing and Access Legend...

Recent company news

Stock data

Close
16.10 USD
Market cap
6.74B USD
Exchange
NASDAQ
Sector
CAR-T Therapy, TCR-T Therapy, Antibody Drugs, ADCs, Biopharma
Location
United States